Radiological Imaging of Viral Pneumonia Cases Identified Before the COVİD-19 Pandemic Period and COVİD-19 Pneumonia Cases Comparison of Characteristics (original) (raw)
Related papers
Comparison of Radiographic Appearances of Covid-19 Pneumonia and Influenza Pneumonia
Background The novel coronavirus (COVID-19) first discovered in December 2019 has infected over 400 million people worldwide with over 5 million deaths as of February 2022. Differentiation of the imaging appearance of COVID-19 pneumonia and the endemic seasonal influenza pneumonia is clinically important as it may help give direction on patient care. The aim of this study was to evaluate for differences in radiographic appearances of COVID-19 pneumonia and influenza pneumonia. Methods This was a cross sectional descriptive study comparing patterns of pneumonia on radiographs and CT examinations of patients diagnosed with COVID-19 pneumonia and influenza pneumonia. The comparisons included the predominant radiographic pattern of pneumonia (alveolar, interstitial, ground glass or nodular) and the extent of pneumonia (lobar, multi-lobar or diffuse involvement). The radiographic severity of disease was classified as mild, moderate or severe based on extent of lung involvement. Results A...
Diagnostics, 2021
Imaging plays an important role in the detection of coronavirus (COVID-19) pneumonia in both managing the disease and evaluating the complications. Imaging with chest computed tomography (CT) can also have a potential predictive and prognostic role in COVID-19 patient outcomes. The aim of this pictorial review is to describe the role of imaging with chest X-ray (CXR), lung ultrasound (LUS), and CT in the diagnosis and management of COVID-19 pneumonia, the current indications, the scores proposed for each modality, the advantages/limitations of each modality and their role in detecting complications, and the histopathological correlations.
Current Imaging Trends in COVID-19 Pneumonia
Journal of Nepal Medical Association, 2020
COVID-19 has rapidly emerged as a pandemic threatening lives and healthcare systems worldwide.With the emergence of the disease in Nepal, all faculties of medicine need to be well prepared toface the challenge. Fortunately, now plenty of research is available to facilitate our preparednessin the war against COVID-19. The reverse transcriptase-polymerase chain reaction is the currentgold standard diagnostic test and chest Computed Tomography scan for screening the disease isconsidered inappropriate by most society recommendations. The Nepal Radiologists’ Associationhas proposed its guidelines which have been endorsed by the Nepal Medical Council. This articleaims to summarize the role of imaging focusing on chest X-ray and Computed Tomography scanincluding the indications, specific findings, and important differentials. Imaging needs to be donetaking necessary precautions, to minimize disease transmission, protect health care personnel, andpreserve health care system functioning.
The Radiology of COVID-19 Pneumonia
2021
Coronavirus disease 2019 (COVID-19) has reached a pandemic stage in March 2020 and currently more than 220 million patients worldwide are infected. The characteristic findings of COVID-19 pneumonia are bilateral, peripheral, rounded ground-glass opacities (GGO) which are dominantly located in the lower lobes and that may be accompanied by consolidation. The distribution of the parenchymal lesions was reported to be bilateral (88%), multi-lobar (78%) and peripheral (76%), with a tendency to involve the posterior regions of the lungs (80%). Several other chest CT findings, such as interlobular septal thickening, bronchiectasis, "crazy paving" and halo sign, have also been reported but with a lower frequency. RSNA has published consensus statements to reduce report variability among radiologists and defined 4 main categories: typical, indeterminate, atypical, and negative, to provide a relative likelihood that these findings are attributable to COVID-19 pneumonia. It is vital to understand that imaging may be normal in the early stages of COVID-19, and many conditions may present with imaging findings mimicking COVID-19 pneumonia. Chest CT may be also used as a useful tool for better identification of patients who will benefit from more aggressive therapy. In addition, CT may be used to evaluate patency of pulmonary and coronary vascular structures and myocardial damage. Although CT scan is not recommended as a diagnostic and screening tool, it can be helpful to clinician for a fast and accurate decision-making and has a crucial role in the diagnosis, risk stratifying, and follow-up of the progression of COVID-19 pneumonia.
Canadian Journal of Infectious Diseases & Medical Microbiology, 2022
Background. orax computed tomography (CT) imaging is widely used as a diagnostic method in the diagnosis of coronavirus disease 2019 (COVID-19)-related pneumonia. Radiological di erential diagnosis and isolation of other viral agents causing pneumonia in patients have gained importance, particularly during the pandemic. Aims. We aimed to investigate whether there is a di erence between CT images from patients with COVID-19-associated pneumonia compared to CT images of patients with pneumonia due to other viral agents and which nding may be more e ective in diagnosis. Study Design. e study included 249 adult patients with pneumonia identi ed by thorax CT examination and with a positive COVID-19 RT-PCR test compared to 94 patients diagnosed with non-COVID-19 pneumonia (viral PCR positive but no bacterial or fungal agents detected in other cultures) between 2015 and 2019. CT images were retrospectively analyzed using the PACS system. CT ndings were evaluated by two radiologists with 5 and 20 years of experience, in a blinded fashion, and the outcome was decided by consensus. Methods. Demographic data (age, gender, and known chronic disease) and CT imaging ndings (percentage of involvement, number of lesions, distribution preference, dominant pattern, ground-glass opacity distribution pattern, nodule, tree in bud sign, interstitial changes, crazy paving sign, reversed halo sign, vacuolar sign, halo sign, vascular enlargement, linear opacities, traction bronchiectasis, peribronchial wall thickness, air trapping, pleural retraction, pleural e usion, pericardial e usion, cavitation, mediastinal/hilar lymphadenopathy, dominant lesion size, consolidation, subpleural curvilinear opacities, air bronchogram, and pleural thickening) of the patients were evaluated. CT ndings were also evaluated with the RSNA consensus guideline and the CORADS scoring system. Data were divided into two main groups-non-COVID-19 and COVID-19 pneumonia-and compared statistically with chi-squared tests and multiple regression analysis of independent variables. Results. RSNA and CORADS classi cations of CT scan images were able to successfully di erentiate between positive and negative COVID-19 pneumonia patients. Statistically signi cant di erences were found between the two patient groups in various categories including the percentage of involvement, number of lesions, distribution preference, dominant pattern, nodule, tree in bud, interstitial changes, crazy paving, reverse halo vascular enlargement, peribronchial wall thickness, air trapping, pleural retraction, pleural/pericardial e usion, cavitation, and mediastinal/hilar lymphadenopathy (p < 0.01). Multiple linear regression analysis of independent variables found a signi cant e ect in reverse halo sign (β 0.097, p < 0.05) and pleural e usion (β 10.631, p < 0.05) on COVID-19 pneumonia patients. Conclusion. e presence of reverse halo and absence of pleural e usion was found to be characteristic of COVID-19 pneumonia and therefore a reliable diagnostic tool to di erentiate it from non-COVID-19 pneumonia.
chest imaging features of coronavirus disease 2019 pneumonia: a systematic review and meta-analysis
Minerva Respiratory Medicine, 2022
INTRODUCTION: This study aimed to systematically review the evidence reporting the key imaging findings in confirmed COVID-19 pneumonia. EVIDENCE ACQUISITION: A systematic search for articles reporting the prevalence of imaging findings in patients with covid-19 pneumonia was conducted in seven databases up to april 10, 2020. the study protocol was registered in prospero (crd42020172528). EVIDENCE SYNTHESIS: A total of 25 imaging features were identified in 29 studies. The most characteristic radiographic features of covid-19 pneumonia include peripheral distribution (92.4%, 95% ci: 86.8-95.8), bilateral involvement (82.8%, 95% ci: 76.0-87.9), and ground-glass opacities (GGo) (76.0%, 95% ci: 59.5-87.3). right lower lobe (rLL) was the most frequently involved lobe (89.0%, 95% ci: 79.6-94.4), followed by left lower lobe (LLL) in 86.5% (95% ci: 74.8-93.2) of patients. the atypical imaging features included bronchial wall thickening, lymphadenopathy, and pleural effusion, which were observed more commonly in severe and critical covid-19 pneumonia compared to mild and moderate condition. concLUsions: chest imaging can help to diagnose covid-19 pneumonia, especially in regions where the availability of rt-pcr testing kits is limited. recognition of key radiographic features of covid-19 pneumonia is essential to identify patients at early stages, monitor disease progression, and optimize their management plan.
Rational and practical use of imaging in COVID-19 pneumonia
Pakistan Journal of Medical Sciences, 2020
The severe form of the COVID-19 pandemic caused by the SARS-CoV-2 virus, has largely manifested as a predominant respiratory illness causing severe pneumonia characterized by bilateral, subpleural ground glass haze, progressing to consolidation, and fibrosis on imaging. There is some discrepancy between the governmental guidelines, professional Societies and Radiology and Respiratory Medicine specialists with divided opinions between the use of the chest X-rays and CT scan, and whether the use be screening or diagnostic. So far, the most balanced recommendations have been proposed by the Fleischner Society, which are endorsed by the Radiological Society of Pakistan as well. This writeup describes the approach for a rational use of imaging to the best advantage in the current situation according to local resources, and restricting the spread of infection. The most practical compromise for Pakistan appears to be the use of portable digital radiography equipment, and point-of- care ult...
COVID-19 pneumonia: current evidence of chest imaging features, evolution and prognosis
Chinese Journal of Academic Radiology, 2021
COVID-19 pneumonia represents a global threatening disease, especially in severe cases. Chest imaging, with X-ray and high-resolution computed tomography (HRCT), plays an important role in the initial evaluation and follow-up of patients with COVID-19 pneumonia. Chest imaging can also help in assessing disease severity and in predicting patient's outcome, either as an independent factor or in combination with clinical and laboratory features. This review highlights the current knowledge of imaging features of COVID-19 pneumonia and their temporal evolution over time, and provides recent evidences on the role of chest imaging in the prognostic assessment of the disease.
Challenges in the Differential Diagnosis of COVID-19 Pneumonia: A Pictorial Review
Diagnostics
COVID-19 pneumonia represents a maximum medical challenge due to the virus’s high contagiousness, morbidity, and mortality and the still limited possibilities of the health systems. The literature has primarily focused on the diagnosis, clinical-radiological aspects of COVID-19 pneumonia, and the most common possible differential diagnoses. Still, few studies have investigated the rare differential diagnoses of COVID-19 pneumonia or its overlap with other pre-existing lung pathologies. This article presents the main radiological features of COVID-19 pneumonia and the most common alternative diagnoses to establish the vital radiological criteria for a differential diagnosis between COVID-19 pneumonia and other lung pathologies with similar imaging appearance. The differential diagnosis of COVID-19 pneumonia is challenging because there may be standard radiologic features such as ground-glass opacities, crazy paving patterns, and consolidations. A multidisciplinary approach is crucial...
Mustafa Fayadoglu, 2021
The coronavirus disease-2019 (COVID-19) pneumonia which is caused by the severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) virus is the current urgent issue world over. According to the Health Ministry of Turkey, the first COVID-19 patient was diagnosed on March 11, 2020. Since then, approximately 5.5 million patients have been confirmed to be positive SARS CoV-2 virus. In this retrospective study, we aimed at analyzing the epidemiological and radiological findings of COVID-19 cases at the Hospital of Grand National Assembly of Turkey from April 1, 2020 to December 31, 2020. A total of 130 patients (84 male, 25-87 years) were diagnosed as positive with High Resolution Computed Tomography (HRCT) scans and 71 of them confirmed with positive Real Time Polymerase Chain Reaction using the patients' nasopharyngeal and throat samples. HRCT scans were classified into 4 stages. Stage I (39.2%) patients' group; the HRCT results were found to be mosaic perfusion, whereas Stage II (39.2%) were found to be Ground Glass Opacity. Also, consolidation was detected in Stage III (20%). Finally, Stage IV, considered the most severe lung findings, and named as a crazy paving pattern was determined in 2 patients (1.53%). Furthermore, 20% of patients were found to be positive using IgG antibody against to SARS CoV-2 virus. Our findings showed that HRCT could be most prominent technique compared to real time polymerase chain reaction for the diagnosis of COVID-19 pneumonia. The novel classification of HRCT findings will be helpful to early diagnosis of the disease, time saving and eventually cost-effective. Abbreviations: COVID-19 = coronavirus disease-2019, GGO = ground glass opacity, HRCT = high resolution computed tomography, RT-PCR = real time polymerase chain reaction, SARS CoV-2 = severe acute respiratory syndrome coronavirus-2.